To explore the utility of the baculovirus/insect-cell system for the expression of a soluble secreted human insulin-receptor (hIR) (a-plus truncated fl-subunits). None of these hIR species exhibit 0-linked carbohydrate. Only the processed form of the receptor in the medium binds insulin. This insulin-binding protein is secreted as a dimer (af)2, and binds insulin with an affinity which is comparable with that of both the wild-type hIR as well as the secreted form of the hIR expressed in mammalian cells. Despite the rather inefficient processing and altered glycosylation of the AchIR01 protein in insect cells, this high-affinity insulin-binding protein accumulates in the medium at levels (mg/litre) of about 100 times that achieved in a mammalian-cell system.
INTRODUCTION
The Spodoptera frugiperda (fall armyworm) (Sf9) insect-cell system has proved to be an effective method for the production of significant (milligram) quantities of a variety of proteins by the use of recombinant baculovirus (Autographa californica) expression vectors [for a review, see Luckow & Summers, 1988] . There are as yet only a few examples of the use of this system for the synthesis ofmammalian transmembrane glycoproteins (e.g. Greenfield et reviewed in Luckow & Summers, 1988) , and significant differences in the glycosylation patterns of insect and mammalian cells have been reported Hsieh & Robbins, 1984; reviewed in Kornfeld & Kornfeld, 1985) . Whereas . Thus a prerequisite for the use of the baculovirus/Sf9 system for the expression of a complex mammalian glycoprotein is the demonstration that such potential alterations in carbohydrate composition do not adversely effect the biological properties and/or physiological function of the protein of interest.
The insulin receptor (IR) is a disulphide-linked heterotetramer (af)2, whose biosynthesis is rather complex (for a recent discussion, see Olson et al., 1988) . The IR is synthesized as a single-polypeptide-chain precursor (1355 amino acids; Mr 153917) that is proteolytically cleaved after dimerization into ac-subunits (735 amino acids;
Mr 84214) and fl-subunits (620 amino acids; Mr 69703).
Both subunits of the IR are glycosylated at asparagine residues (Olson & Lane, 1987) . There are 13 potential Nlinked glycosylation sites in the a-subunit, and four in the fl-subunit (Ebina et al., 1985) . Glycosylation of the IR precursor is a prerequisite for both the acquisition of insulin binding and for cleavage into a-and f-subunits, as the IR expressed in cells treated with tunicamycin does not bind insulin and is not processed; however, the carbohydrate can subsequently be enzymically removed from the glycosylated precursor without compromising the ability of the protein to bind insulin (Olson & Lane, 1987 domain, with 929 residues extracellularly (all of the asubunit and about one-third of the fl-subunit) and 403 residues in the cytoplasm (the C-terminal two-thirds of the fl-subunit). Both of these large domains have now been engineered (truncated) and expressed as discrete, soluble molecules in mammalian cells: i.e. a secreted functional dimer of the extracellular domain which binds insulin with high affinity (Ellis et al., 1988b ; see also Whittaker & Okamoto, 1988) , and a monomeric cytoplasmic domain with the expected tyrosine-specific protein kinase activity (Ellis et al., 1987) . These findings suggest a new experimental strategy to explore the structure of the functional domains of such large complex transmembrane glycoproteins, provided that each domain can be produced in sufficient quantity for biochemical, and ultimately structural, analysis (Ellis, 1988) . The baculovirus system has now been successfully employed for the expression of the soluble human IR protein-tyrosine kinase domain in Sf9 cells (Ellis et al., 1988a; Herrera et al., 1988) , and -10 mg of this enzyme have been routinely purified from -800 ml of cultured cells (B. Clack & L. Ellis, unpublished work) . In the present study we explored the feasibility of using this expression system for the synthesis of a secreted soluble hIR extracellular ligand-binding domain.
MATERIAL AND METHODS
All manipulations of DNA were carried out by the use of standard procedures (Maniatis et al., 1982) . Enzymes were from New England Biolabs or Boehringer Mannheim. Plasmids were propagated in the DH1 strain of Escherichia coli (Hanahan, 1983) .
A -3 kb cDNA fragment encoding 921 of the extracellular amino acids of the hIR was derived from plasmid pehIRO1, a -5.8 kb simian-virus-40 (SV40) early promotor expression vector designed to express the extracellular domain of the hIR as a soluble secreted protein in mammalian cells (Ellis et al., 1988b) . The truncated hIR protein encoded by this plasmid, designated 'hIRO 1', contains 921 residues derived from the hIR (all of the asubunit and all of the extracellular portion of the ,-subunit, except for eight amino acids prior to the transmembrane domain) and two residues (Ala-Arg) derived from polylinker sequences of the pECE expression vector (Ellis et al., 1986 where the first methionine residue is Met + 1 of polyhedrin, the arginine and proline residues are derived from the vector sequence (including the SmaI site) and the second methionine is Met -27 of the signal peptide of the hIR (Ebina et al., 1985) . Thus this plasmid configuration results in the addition of three amino acids to the signal peptide of the hIR. The above DNA sequence was confirmed by subcloning an 300-bp EcoRV [which cuts 5' at bp -98 of the polyhedrin gene (Summers & Smith, 1987) and 3' at a unique site at bp 253 of the hIR (Ebina et al., 1985) ] fragment which includes this junction into the unique SmaI site of M13mpl9 (Yanish-Perron et al., 1985) and determining the nucleotide sequence of both strands of the fragment by the dideoxy-chainterminator method (Sanger et al., 1977) . Plasmid pAch-IROI also includes the 245-bp 3'-untranslated sequences with polyadenylation signals of SV40 origin (derived from the pehIR01 plasmid; see above), followed (3' to the BamHI site, which is the unique BamHI site located at bp + 171 of the polyhedrin gene) by interrupted (and now non-coding) polyhedrin gene sequences [see Fig. 1 of Ellis et al. (1988a) and Figs. 3 and 5 of Summers of Smith (1987) ]. Plasmid pAchIR01 was used to transfect Sf9 cells and recover recombinant virus encoding the AchIR01 protein by the methods described by Summers & Smith (1987) . All of the experiments described herein utilized a single recombinant virus designated 'AchIR01 D8.2'. Sf9 cells were seeded into flasks at a density of 3 x 101 cells/25 cm2 flask. After attachment of the cells the medium was removed and virus inoculum was added (in a total volume of 1 ml) at a multiplicity of infection (MOI) of 10. After 1 h of incubation at 27 IC, 4 ml of complete culture medium was added.
Metabolic labelling of cells, immunoprecipitation of labelled proteins and gel-filtration chromatography were as described by Ellis et al. (1986 Ellis et al. ( , 1988a . The binding of insulin [mono[1251] iodinated porcine insulin (90,uCi/ ,ug) from New England Nuclear and unlabelled porcine insulin from Lily] to AchIR01 protein immobilized by anti-IR monoclonal antibodies on microtitre plates was done as described by and Ellis et al. (1988b) . EndoH, neuraminidase and 0-glycanase were purchased from Genzyme (Boston, MA, U.S.A.), and endo F was from du Pont/New England Nuclear (Wilmington, DE, U.S.A.); all of these enzymes were used according to the manufacturer's instructions. (Roth et al., 1982; Soos et al., 1986) of the insulin-binding protein secreted into the medium of Sf9 cells infected with AchIR01 virus The solid-phase assay was as in Fig. 1 Immunoprecipitates were prepared with anti-IR mAb 83.14 (Soos et al., 1986 ) from either non-ionic-detergent (Triton X-100) extracts of cells (lanes 3 and 4) or from culture medium (lanes 1 and 2) . Analysis was by SDS/ PAGE on 10% (w/v) gels and fluorography. Molecular masses (M) of standard proteins are indicated at the left of this, and subsequent, Figures. ( Ellis et al., 1988b ) employing a panel of anti-IR monoclonal antibodies (mAbs; Roth et al., 1982; Soos et al., 1986) Soos et al., 1986; Fig. 3) . After 6 h of chase, most of the labelled protein specifically recognized by IR mAb is present in the cell extract, and migrates with an Mr of 138000 [as estimated by SDS/polyacrylamide-gel electrophoresis (PAGE) on 10% (w/v) gels], as expected for the glycosylated precursor (lane 3; the deduced M, of the precursor is 105 119). A polypeptide of the same size is also present in the medium (lanes 1 and 2) . After 24 h of chase, -50 % of the labelled protein is still present as precursor in cell extracts (lane 4). Of the remaining -50 % now in the medium, one labelled band has the same Mr as that of the intracellular precursor, whereas the second has an Mr of -108000, as expected for the glycosylated a-subunit after cleavage of the precursor (lane 2; the deduced Mr of the a-subunit is 84214). The difference in size of these two bands, namely -29000, is about that expected for the glycosylated extracellular portion of the truncated f-subunit, whose deduced Mr is 20905. To reveal this smaller band requires a longer exposure of the film than that in Fig. 3 (see Fig. 4 below) . Note that the processed a-subunit is also detectable intracellularly in cell extracts, although in quantities substantially less than that of the presursor (Fig. 3, lanes 3 and 4) ; this intracellular processed receptor is likely to account for the small increase in insulin binding observed in cell extracts during the time course of the infection (cf. Fig. lb) . Thus these pulse-chase experiments demonstrate that the biosynthesis of the extracellular domain of the hIR in this cell system is somewhat inefficient, as a substantial fraction of the polypeptide accumulates inside the cell as a non-processed precursor which does not bind insulin (cf. Fig. lb) .
The AchIR01 protein is glycosylated
Treatment of the intracellular precursor after 24 h of chase (see above) with endoH, which cleaves between the di-GlcNAc residues of high-mannose (non-complex) oligosaccharide chains , results in the increase in the mobility of the protein (Mr -135000; as estimated by SDS/PAGE on 5-15 % gradient gels) to an Mr ( 110000) close to that deduced for the non-glycosylated precursor (105 119), which suggests that all of the N-linked carbohydrate attached to the precursor is of the high-mannose form ( Fig. 4; cf. lanes 2 and 4) . This change in mobility ( 25000) Hsieh & Robbins, 1984) . Glycoproteins or glycopeptides with trimannosyl oligosaccharide chains are very poor substrates for digestion by endoH , 1975 Trimble et al., 1978) , although the glycosylated amino acid Man3(GlcNAc)2Asn is a very good substrate (Trimble et al., 1978) . After intracellular transit and secretion into the medium, about one-half Qf the N-linked carbohydrate chains of the non-cleaved precursor (Mr) are now endoHresistant: with endoH digestion, the secreted precursor migrates with an Mr of -120000, a change of -10000, the equivalent of about three N-linked chains (Fig. 4, cf.  lanes 1 and 3) . Note that a band of this Mr is also present in the endoH-digested extract (Fig. 4, lane 4) , which is likely to be the non-processed precursor destined for secretion. The proteolytically processed a-subunit (Mr -106000) has an estimated three N-linked endoHsensitive chains, as its Mr after digestion is -95000 (a change of -10000; Fig. 4, cf. lanes 1 and 3) . The small extracellular portion of the , 8-subunit, visible in Fig. 4 at an Mr of -24000, is endoH-resistant (Fig. 4, cf. lanes 1  and 3, lower band) . The fl-chain is glycosylated, however, as it is sensitive to digestion with endoF, which cleaves between the di-GlcNAc residues of high-mannose, trimmed-mannose or complex oligosaccharide chains (Elder & 0-linked oligosaccharide chains attached to serine and/ or threonine residues (Endo & Kobata, 1976; Umemoto et al., 1977) is without effect on all of these forms of the AchIR01 protein (results not shown). Thus the trimming of the high-mannose oligosaccharide chains initially attached to the intracellular AchIROI precursor (see above) is heterogeneous, as has been observed for other glycoproteins synthesized in insect cells (see the Introduction).
The secreted AchIR01 protein is a dimer The wild-type hIR is isolated in non-ionic-detergent extracts of cells and tissues as a disulphide-linked heterotetramer of (az/)2. stoichiometry (Kasuga et al., 1982; Fujita-Yamajuchi, 1984; Kramer et al., 1987) . The hIR dimerizes in the endoplasmic reticulum before proteolytic cleavage of the precursor (Olson et al., 1988) . To assess potential oligomerization of the secreted AchIR01, culture medium harvested 48 h after infection of Sf9 cells with the AchRI01 virus was fractionated by gel-filtration chromatography on a Sephacryl S-300 column (exclu- as compared with its counterpart secreted from a stably transfected mammalian (CHO, Chinese-hamster ovary) cell Une [the CHO.hIR01 cells described by Ellis et at. (1988b) : Al and with the wild-type membrane associated hIR synthesized in a stably transfected mammalian (CHO) cell line [the CHO.T cells described by Ellis et al. (1986) : El "211-insulin binding to each receptor was measured by the solid phase assay in the presence of increasing concentrations of unlabelled porcine insulin (Lily). Results are expressed as a percentage of the 1251-insulin bound in the absence of unlabelled insulin. Individual points represent the average of three determinations of each concentration.
sion-limit M, -1.5 x 106; Fig. 5 ). The insulin-binding protein is eluted with an Mr equivalent to that of ferritin (Mr -440000), which is consistent with a dimeric Ach-IROI molecule. The chromatographic behaviour of the protein secreted from Sf9 cells is in fact indistinguishable from that of its counterpart secreted from mammalian cells (see Fig. 5 of Ellis et al., 1988b) . Covalent crosslinking of the fractions under the Sephacryl S-300 peak with 'l25-insulin, followed by SDS/PAGE and autoradiography, reveals a single species of insulin-binding protein that migrates on reducing gels coincident with the processed a-subunit (Fig. 6, lanes 1 and 2; cf. lane 2 of Fig. 3 ). The secreted non-processed precursor is also a dimer, and is co-eluted with the processed-receptor dimer under the same peak upon gel-filtration chromatography; thus the non-processed secreted precursor does not bind insulin (results not shown).
Further evidence of heterogeneity of attached carbohydrate chains on the AchIR01 protein derives from the behaviour of the Sephacryl S-300 peak material (e.g. that of Fig. 5 ) on a wheat-germ agglutinin-agarose column (WGA), which specifically binds glycoconjugates bearing N-acetylglucosamine or sialic acid residues (Bhavanandan & Katlic, 1979; Monsigny et al., 1980) . Sialyltransferases have not been detected in insect cells, and thus insect carbohydrates do not contain sialic acid . Consistent with these reports, none of the forms of the AchIR01 protein are sensitive to digestion with neuraminidase (acetylneuraminyl hydrolase : Hughes & Jeanloz, 1964; Kiyohara et al., 1974 ; not shown). The AchIROI protein specifically binds to WGA and is eluted with a broad trailing peak upon addition of the relevant hapten (i.e. 0.3 M-N-acetylglucosamine; Fig. 7 ). In contrast, the wild-type hIR synthesized in mammalian cells (the CHO.T cells of Ellis et al., 1986) Fig. 7 results in the labelling of a single species that co-migrates on reducing gels with the processed oc-subunit of the receptor (Fig. 6,  lanes 3 and 4) . AchIR01 also binds to concanavalin A (specific for mannose residues), but is eluted with neither hapten nor 1 M-NaCl. The protein does not bind to soybean agglutinin, which is specific for N-acetylgalactosamine residues such as are added to serine and/or threonine residues of some insect glycoproteins , consistent with the lack of sensitivity to digestion of AchIRO1 with O-glycanase (results not shown). The AchIR01 protein binds insulin with high affinity
To assess the affinity of the secreted AchIROl for insulin, the protein was immunoaffinity-purified by a solid-phase method Ellis et al., 1988b) and incubated with increasing concentrations of unlabelled porcine insulin (Lily) in the presence of -80 pM-125I-insulin (Fig. 8a) . The concentration of unlabelled porcine insulin required to inhibit half-maximal binding of labelled insulin is -10-9 M, which is quite comparable with that required for similar inhibition of insulin binding by both the hIR01 protein secreted from mammalian cells ( Fig. 8a; see Ellis et al., 1988b) and the wild-type membrane bound hIR expressed in mammalian cells ( Fig. 8b ; the CHO.T cells of Ellis et al., 1986) . Analysis of the binding data of Fig. 8(b) by the Scatchard method (Scatchard, 1949; Munson & Rodbard, 1980) illustrates that, like its mammalian counterpart (i.e. hIRO1), AchIRO1 exhibits a linear Scatchard plot, whereas that of the wild-type membrane bound hIR exhibits a curvilinear plot [ Fig. 9 Fig. 9 . Analysis of the 'l25-insulin-binding data of Fig. 8 by the Scatchard method (Scatchard, 1949; Munson & Rodbard, 1980 
